Pari Homepage

Results will be updated as you type

News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

Digital illustration of lungs with connected data structures and technical graphics, featuring the eFlow® Technology logo.

Categories

  • PARI News
  • Partner News
  • PARI Publications
  • Publications
  • eFlow Integrated

Posts of category: Partner News

Recent announcements, achievements, and development milestones from PARI's pharmaceutical partners utilizing eFlow® Technology.

Published
September 5, 2023
Category
  • Partner News

Insmed Announces Positive Topline Results From Phase 3 ARISE Study of ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with NTM Lung Disease Caused by MAC

Published
June 27, 2023
Category
  • Partner News

Savara Completes Enrollment of Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Published
May 2, 2023
Category
  • Partner News

Zambon Completes Enrollment in Phase 3 Clinical Development Program Evaluating Liposomal Cyclosporine A for Inhalation (L-CsA-i) in Patients with Bronchiolitis Obliterans Syndrome (BOS)

Published
April 18, 2023
Category
  • Partner News

First Patient Enrolled in Phase 3 Clinical Trial Evaluating ARINA-1 in Lung Transplant

Published
March 30, 2023
Category
  • Partner News

Renovion Receives FDA Fast Track Designation for ARINA-1 for the Prevention of BOS Progression in Lung Transplant Patients

Previous page
of 11
Next page

Back to overview

  1. eFlow Partnering
  2. News & Publications
  3. Categories
Link to PARI at LinkedIn

+49 (0) 8151 279 279
 

Contact

  • Career
  • Press portal
  • Partner with us
  • PARI INT
  • Imprint
  • Data Protection
  • Cookie Consent
  • Accessibility Statement
  • General Terms and conditions

© 2026 PARI GmbH Spezialisten für effektive Inhalation